Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s55, 2020. DOI: 10.25251/skin.4.supp.54. Disponível em: https://skin.dermsquared.com/skin/article/view/1000. Acesso em: 23 apr. 2025.